Article info

Download PDFPDF

Original research
Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

Authors

  1. Correspondence to Dr Marjolijn N Lub-de Hooge; m.n.de.hooge{at}umcg.nl
View Full Text

Citation

Waaijer SJ, Giesen D, Ishiguro T, et al
Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate

Publication history

  • Accepted March 3, 2020
  • First published March 26, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.